{"product_id":"ccnd2-antibody-sc-f0376","title":"Cyclin D2 Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003eCCND2 is a target of interest in many antibody-based workflows. The activity of cyclin-dependent kinases CDK4 and CDK6 is controlled by T-loop phosphorylation, the availability of their cyclin partners (D-type cyclins), and interaction with CDK inhibitors from the Cip\/Kip or INK protein families. The inactive ternary complex of cyclin D\/CDK4 and p27 Kip1 requires extracellular mitogenic signals for p27 release and degradation, alongside an increase in cyclin D levels, to enable progression through the restriction point and Rb-dependent entry into the S-phase. Depending on the literature source, CCND2 may also be discussed as Cyclin D2 and G1\/S-specific cyclin-D2.\u003c\/p\u003e\u003cp\u003eReported cellular context includes cytoplasm, membrane, and nucleus, which can matter when signal is compared across treatments or changing cell states. Following CCND2 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003eCCND2 is commonly interpreted in the context of cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm, membrane, and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eapparent redistribution between cytoplasm, membrane, and nucleus across matched conditions\u003c\/li\u003e\n\u003cli\u003esignal-dependent shifts after ligand, inhibitor, or growth-factor perturbation\u003c\/li\u003e\n\u003cli\u003eco-patterning with orthogonal markers and control conditions that clarify pathway state\u003c\/li\u003e\n\u003cli\u003etime-matched comparisons so changes reflect biology rather than handling or sampling drift\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for CCND2. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in CCND2 reflect biology rather than handling. When interpreting CCND2, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep CCND2 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57577448112473,"sku":"F0376-20UL","price":139.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57577448145241,"sku":"F0376-100UL","price":329.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57577448178009,"sku":"F0376-2X100UL","price":489.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F0376-wb.gif?v=1773598393","url":"https:\/\/absource-diagnostics.myshopify.com\/products\/ccnd2-antibody-sc-f0376","provider":"Absource Diagnostics","version":"1.0","type":"link"}